Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02071732
Other study ID # 2014-002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2014
Est. completion date August 2021

Study information

Verified date August 2021
Source Dongtan Sacred Heart Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether repetitive transcranial magnetic stimulation (rTMS) is effective in the treatment of tinnitus.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date August 2021
Est. primary completion date August 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subjective tinnitus - Age 18 years and older Exclusion Criteria: - Meniere, conductive hearing loss, objective tinnitus - History of seizure disorder or epilepsy - Clinically relevant psychiatric comorbidity - Previous symptomatic stroke - Surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), intracardiac lines that may pose a physical hazard during magnetic stimulation

Study Design


Related Conditions & MeSH terms

  • Patients With Subjective Tinnitus
  • Tinnitus

Intervention

Device:
real repetitive Transcranial Magnetic Stimulation

sham repetitive Transcranial Magnetic Stimulation
This sham stimulation is not true stimulation.

Locations

Country Name City State
Korea, Republic of Department of Neurology, and Department of Otorhinolaryngology-Head & Neck Surgery Dongtan Sacred Heart Hospital Hwaseong-si Gyeonggi-do

Sponsors (1)

Lead Sponsor Collaborator
Dongtan Sacred Heart Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tinnitus handicap inventory score Primary outcomes will be measured twice. One is before, and the other is after 5-day rTMS interventions. Baseline primary outcome will be acceptable if it is done within the prior 6 months of 1st rTMS. Follow-up primary outcome will be done within the five days after 5th rTMS. Before (- six months) and after (+ 5 days) rTMS interventions